PetCaseFinder

Peer-reviewed veterinary case report

Screening proteins linked to steroid-responsive meningitis-arteritis

By Nessler, Jasmin Nicole & Tipold, Andrea·Published in PloS one·2023·Department of Small Animal Medicine and Surgery, Germany·View original on PubMed

PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →

Original publication title: Immunoglobulin profiling with large high-density peptide microarrays as screening method to detect candidate proteins for future biomarker detection in dogs with steroid-responsive meningitis-arteritis.

Species:
dog

Plain-English summary

A group of dogs with steroid-responsive meningitis-arteritis (SRMA), a serious inflammatory condition affecting the brain and spinal cord, showed different immune responses compared to dogs with neck pain from intervertebral disc herniation. Researchers found that the dogs with SRMA had specific antibodies targeting a protein called interleukin 1 receptor antagonist (IL1Ra), which is known to help reduce inflammation. This suggests that IL1Ra could be a potential marker for diagnosing SRMA in the future. Understanding these immune responses may help veterinarians better identify and treat this condition in dogs.

People also search for: dog meningitis treatment · SRMA symptoms in dogs · interleukin 1 receptor antagonist in dogs

Abstract

UNLABELLED: Steroid responsive meningitis arteritis (SRMA) is an aberrant Th2-mediated systemic inflammatory disease in dogs. The etiopathogenesis still remains unclear as no triggering pathogen or autoantigen could be found so far. HYPOTHESIS: Large high-density peptide microarrays are a suitable screening method to detect possible autoantigens which might be involved in the pathogenesis of SRMA. METHODS: The IgA and IgG profile of pooled serum samples of 5 dogs with SRMA and 5 dogs with neck pain due to intervertebral disc herniation (IVDH) without ataxia or paresis were compared via commercially available high-density peptide microarrays (Discovery Microarray) containing 29,240 random linear peptides. Canine distemper virus nucleoprotein (CDVN) served as positive control as all dogs were vaccinated. Common motifs were compared to amino acid sequences of known proteins via databank search. One suitable protein was manually selected for further analysis with a smaller customized high-density peptide microarray. RESULTS: Pooled serum of dogs with SRMA and IVDH showed different IgA and IgG responses on Discovery Microarray. Only top IgG responses of dogs with SRMA showed a common motif not related to the control protein CDVN. This common motif is part of the interleukin 1 receptor antagonist protein (IL1Ra). On IL1Ra, dogs with SRMA displayed IgA binding to an additional epitope, which dogs with IVDH did not show. DISCUSSION: IL1Ra is an anti-inflammatory acute phase protein. Different immunoglobulin binding patterns on IL1Ra could be involved in the pathogenesis of SRMA and IL1Ra might be developed as future biomarker for SRMA.

Find similar cases for your pet

PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.

Search related cases →

Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/37036858/